GlassScriptPhysician profile
Toni L Smith
NPI 1093737520
$14,688.74
in general payments reported to CMS, 2019-2025
34 companies · $3,674 in 2025
The $3,674 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,531 · 2022: $2,593 · 2023: $3,861 · 2024: $3,029 · 2025: $3,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,954 · Education: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,953.94 |
| Education | $610.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,316.33 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,981.51 | 2021-2025 | |
| Janssen Biotech, INC. | $1,577.01 | 2021-2025 | Tremfya |
| Genzyme Corporation | $1,150.95 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,119.30 | 2021-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $781.76 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $757.37 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $732.36 | 2021-2025 | Winlevi, Absorica Ld, Ilumya |
| Pfizer INC. | $689.65 | 2021-2025 | |
| Lilly USA, LLC | $616.66 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $442.41 | 2021-2025 | Adbry, Anzupgo |
| Amgen INC. | $342.24 | 2021-2025 | Otezla, Otezla |
| Incyte Corporation | $310.21 | 2021-2025 | Opzelura |
| Ucb, INC. | $296.77 | 2022-2025 | Bimzelx, Cimzia |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $242.41 | 2021-2025 | Cabtreo, Jublia |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $212.56 | 2021-2025 | Oracea, Aklief, Nemluvio |
| Mayne Pharma Commercial LLC | $200.92 | 2025 | |
| Almirall LLC | $163.59 | 2021-2025 | Seysara |
| Verrica Pharmaceuticals INC. | $150.09 | 2023 | Ycanth |
| Epi Health, LLC | $115.69 | 2021-2022 | |
| Dermavant Sciences, INC. | $102.56 | 2023 | Vtama |
| Hill Dermaceuticals, INC. | $89.45 | 2021 | |
| Biogen, INC. | $42.10 | 2021-2025 | Vumerity |
| Vyne Pharmaceuticals INC. | $39.92 | 2021 | |
| Allergan, INC. | $35.75 | 2021 | |
| Mallinckrodt Hospital Products INC. | $34.91 | 2025 | Acthar |
| Neurelis, INC. | $33.16 | 2023 | Valtoco |
| Journey Medical Corporation | $27.69 | 2022-2025 | |
| Organon LLC | $23.50 | 2025 | |
| Botanix Sb INC | $16.46 | 2025 | Sofdra |
| Medimetriks Pharmaceuticals, INC. | $15.08 | 2025 | Genadur, Clindacin Etz, Neo-Synalar |
| Ge Healthcare | $13.04 | 2021 | |
| Sebela Pharmaceuticals INC. | $11.20 | 2021 | |
| Genentech USA, INC. | $4.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toni Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.